Pinning Hopes On A Wider Offering, Boehringer-Lilly Launch DPP-4 Trajenta In A Crowded India Market
This article was originally published in PharmAsia News
Executive Summary
A 30% annual growth in the anti-diabetes market is fueling new launches in India, but competition is getting tougher.